Who is sponsoring NCT05232903?

NCT05232903 is sponsored by Beijing Tiantan Hospital.

What drugs are being tested in NCT05232903?

Interventions in NCT05232903: SVF therapy group.

What condition does NCT05232903 study?

NCT05232903 studies Spontaneous Intracerebral Hemorrhage.

Is NCT05232903 still recruiting?

NCT05232903 is currently status unknown. Last updated 2 March 2022.

Last reviewed 2022-03-02 · How we verify

NCT05232903

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stromal Vascular Fraction (SVF) Therapy in Patients With Acute Spontaneous Intracerebral Hemorrhage (SICH).

Status unknown Phase 1 Last updated 2 March 2022

What this trial tests

Phase 1 trial testing SVF therapy group in Spontaneous Intracerebral Hemorrhage in 15 participants. Status unknown.

Timeline

1 March 2022

Primary endpoint
30 June 2024

30 September 2024

Quick facts

Lead sponsor	Beijing Tiantan Hospital
Phase	Phase 1
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	none
Primary purpose	treatment
Enrollment	15
Start date	1 March 2022
Primary completion	30 June 2024
Estimated completion	30 September 2024
Sites	1 location across China

Drugs / interventions tested

SVF therapy group — full drug profile →

Conditions studied

Spontaneous Intracerebral Hemorrhage — all drugs for Spontaneous Intracerebral Hemorrhage →

Sponsor

Beijing Tiantan Hospital

Who can join

Adults 45 to 55, any sex, with Spontaneous Intracerebral Hemorrhage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this pilot study is to evaluate the safety of stromal vascular fraction (SVF) therapy in patients with spontaneous intracerebral hemorrhage (SICH).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Beijing Tiantan Hospital trials

Trials by the same sponsor.

NCT07341854 — Dexamethasone Palmitate for Postoperative Pain · NA · not yet recruiting
NCT07527013 — Stratified Blood Pressure Management Strategy After Endovascular Treatment for Acute Ischemic Stroke · Phase 3 · not yet recruiting
NCT07520370 — Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor · NA · not yet recruiting
NCT07526987 — Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis · Phase 3 · not yet recruiting
NCT07591207 — The Efficacy and Safety of Loxoprofen Sodium Patch in Relieving Postoperative Pain After Laparoscopic Surgery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05232903 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beijing Tiantan Hospital
Last refreshed: 2 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05232903.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing